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Introduction
Tight junctions, adherens junctions (AJs), and desmosomes 
promote adhesion between epithelial cells, initiate the assembly 
of the mechanical cytoskeleton linkage, and facilitate the for-
mation of a polarized epithelial monolayer (Gumbiner, 1996). 
AJs initiate these processes and are essential for morphogene-
sis, wound healing, and the retention of cell polarity and tissue 
integrity (Perez-Moreno et al., 2003). In epithelia, AJ formation 
is mediated by the calcium-dependent homophilic binding of 
E-cadherin molecules on neighboring cells (Gumbiner, 1996). 
These interactions link adjacent cells and promote the nucle-
ation of a cytoplasmic protein complex consisting of p120-, β-, 
and α-catenins, which bridges E-cadherin clusters and the actin 
cytoskeleton. The biological necessity of AJ proteins has been 
underscored by a high correlation between the malfunctioning 
of AJ proteins, E-cadherin in particular, and tumor metastasis 
(Kang and Massague, 2004).
During tumor progression, the E-cadherin gene can be 
functionally silenced or inactivated by distinct mechanisms 
(Nelson and Nusse, 2004). In addition to transcriptional repres-
sion by SIP-1, δEF-1, Snail/Slug, E12/47, and Twist (Huber 
et al., 2005), posttranslational regulation of E-cadherin stability 
modulates its activity. Precisely tuned exocytic and endocytic 
pathways control the amount of E-cadherin residing on the 
plasma membrane (PM) and are important for modulation of 
E-cadherin function and AJ assembly (Bryant and Stow, 2004). 
Recent evidence suggests that Rab11 (Lock and Stow, 2005), 
p120-catenin, ARF6, tyrosine phosphorylation, and ubiquitina-
tion (D’Souza-Schorey, 2005) all control the traffi  cking and as-
sembly of E-cadherin in mammalian cells. Additionally, transport 
of E-cadherin is regulated by the composition of the cadherin–
catenin complex as well as the vesicular traffi  cking machinery 
(D’Souza-Schorey, 2005), where multiple adaptor and signaling 
proteins orchestrate traffi  cking specifi  city and effi  ciency.
Clathrin adaptor protein (AP) complexes are important in 
the sorting of cargoes containing dileucine or tyrosine-based 
sorting motifs (Bonifacino and Traub, 2003). In epithelial cells, 
AP1B is the unique isoform that mediates basolateral transport 
(Folsch et al., 1999; Folsch, 2005). Although AP1B is closely 
related to the more ubiquitously expressed form of AP1, AP1A, 
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(AJ) is obligatory for establishment of polarized 
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mutation that loses PIPKIγ binding and shows disrup-
ted basolateral membrane targeting no longer forms 
AJs and leads to hereditary gastric cancers. These com-
bined results reveal a novel mechanism where PIPKIγ 
serves as both a scaffold, which links E-cadherin to AP 
complexes and the trafﬁ  cking machinery, and a regula-
tor of trafﬁ   cking events via the spatial generation of 
phosphatidylinositol-4,5-bisphosphate.
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it targets to a distinct membrane compartment defi  ned as the re-
cycling endosome (Folsch et al., 2003; Folsch, 2005). Recently, 
it has been shown that this compartment is an intermediary in 
transport from the Golgi to the PM (Ang et al., 2004) and also 
functions in the recycling of internalized basolateral membrane 
proteins (Gan et al., 2002; Folsch, 2005).
Phosphoinositides are key mediators of membrane traf-
fi  cking (Roth, 2004). Membrane assembly and cargo binding of 
AP2 are both dependent on binding to phosphatidylinositol-4,
5-bisphosphate (PI4,5P2) via its α and μ subunits (Collins et al., 
2002; Honing et al., 2005). There is evidence that other AP 
complexes are also modulated by phosphoinositide lipid mes-
sengers (Baust et al., 2006). In addition, PI4,5P2 regulates actin 
polymerization, focal adhesion assembly, and several components 
of the vesicular traffi  cking machinery (Doughman et al., 2003). 
However, the mechanism by which PI4,5P2 generation is regu-
lated to mediate these traffi  cking events has not been defi  ned.
Recent studies have unveiled that the spatial targeting and 
temporal regulation of type I phosphatidylinositol phosphate 
  kinases (PIPKIs) is a critical mechanism for PI4,5P2 generation 
(Ling et al., 2006). Here we show that in epithelial cells PIPKIγ 
targets to AJs by a direct interaction with the E-cadherin dimer. 
PIPKIγ regulates E-cadherin traffi  cking by acting as a scaffold 
between E-cadherin and AP complexes. We also demonstrate 
that localized generation of PI4,5P2 via these complexes is nec-
essary for E-cadherin transport and AJ formation.
Results
PIPKI𝗄 interacts with cadherins
Upon examination of the basolateral membrane in polarized ep-
ithelial cells, we found that PIPKIγ colocalized with E-cadherin 
(Fig. 1 A) but not with occludin (not depicted). PIPKIγ also 
presented in a cytosolic vesicular compartment and partially co-
localized with E-cadherin at this site (Fig. 1 A, arrows). These 
regions of colocalizion were confi  rmed by constructing vertical 
sections of z-series images shown in Fig. 1 A, suggesting an in-
teraction between PIPKIγ and a component of AJs. To examine 
this possibility, E-cadherin and PIPKIγ were immunoprecipi-
tated. As shown in Fig. 1 B, PIPKIγ and E-cadherin associate 
in vivo, along with other cadherin-associated proteins, demon-
strating that PIPKIγ associates with E-cadherin complexes. 
N-cadherin and VE-cadherin also associate with PIPKIγ 
(Fig. 1 B), suggesting that PIPKIγ associates with the classical 
cadherin complexes.
PIPKIγ is predominantly expressed as two distinct splice 
variants, PIPKIγ635 and PIPKIγ661, which differ by a 26–
amino acid C-terminal extension. HA-tagged PIPKIγ splice 
variants were expressed in human embryonic kidney 293 
(HEK293) cells, and their association with the endogenous 
N-cadherin complex was analyzed. PIPKIγ635 and PIPKIγ661 
both coimmunoprecipitated with N-cadherin indistinguishably 
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/
jcb.200606023/DC1), indicating that this association does not 
depend on the PIPKIγ661 C-terminal extension. However, the 
endogenous PIPKIγ associated with E-cadherin was indistin-
guishable in apparent molecular weight from PIPKIγ661, which 
is the predominant splice variant expressed in these cells. To 
  ascertain whether this association was direct, in vitro GST pull-
down assays were performed using recombinant GST-tagged 
PIPKIγ and His-tagged E-cadherin cytoplasmic domain 
(ECDT). ECDT showed specifi   c binding to both GST-
PIPKIγ635 and GST-PIPKIγ661, but not to GST alone (Fig. 1 C) 
or GST-PIPKIα (Fig. S1 B).
E-cadherin molecules form lateral homodimers in vivo, 
and oligomer formation is critical for AJ assembly and stability 
(Patel et al., 2003). Consequently, we examined if dimerization 
was important for association with PIPKIγ. A parallel dimeric 
ECDT was constructed by inserting a heptad repeat (HR) pep-
tide sequence between the His tag and ECDT (Ling et al., 2003; 
Fig. S1, C and D). The dimeric construct had a greater binding 
affi  nity for PIPKIγ compared with the monomeric protein 
Figure 1. PIPKI𝗄 targets to AJs by a direct interaction with E-cadherin. 
(A) PIPKIγ targets to AJs in both MDCK and MCF10A cells. Horizontal (x-y) 
and vertical (x-z) sections show colocalization of PIPKγ and E-cadherin 
(ECD). Arrows show the vesicular compartments where PIPKIγ and E-cadherin 
colocalize. Bar, 10 μm. (B) PIPKIγ associates with cadherin complexes. 
Immunoprecipitations (IP) and immunoblots (IB) were performed as indi-
cated. NCD, N-cadherin; VECD, VE-cadherin. Normal mouse (mIgG) or 
rabbit IgG (rIgG) were used as controls. (C) PIPKIγ directly and preferen-
tially interacts with the dimerized cytoplasmic domain of E-cadherin. A GST 
pull-down assay was performed using 1 μg of each puriﬁ  ed protein. (D) PIPKIγ 
preferentially binds the E-cadherin dimmer in vivo. Myc-tagged ECDT or 
HR-ECDT was overexpressed in HEK293 cells and immunoprecipitated.PIPKIγ REGULATES E-CADHERIN TRAFFICKING • LING ET AL. 345
(Fig. 1 C). This was not caused by the HR tag because an HR-
fused integrin cytoplasmic domain did not bind PIPKIγ (Ling 
et al., 2003; Fig. S1 E). Moreover, when expressed in cells, the 
Myc-tagged dimeric ECDT (Myc-HR-ECDT) selectively bound 
PIPKIγ and p120-catenin with  10-fold greater affi  nity com-
pared with the monomer (Fig. 1 D and Fig. S1 F). Consistent 
with a previous paper (Huber et al., 2005), β-catenin bound 
the monomeric and dimeric E-cadherin C terminus with the 
same affi  nity.
To further determine whether PIPKIγ binding to 
E-cadherin involves other AJ components, wild-type or mutated 
E-cadherin was expressed in HEK293 cells and assessed for 
 endogenous  PIPKIγ association (Fig. 2 A). Elimination of 
 either  the p120-catenin (ECD∆p120; 
762EED
764 to AAA) or 
β-catenin (ECD∆βctn; ECD847, deletion of the last 35 amino 
acids) binding sites had no effect on PIPKIγ association. 
A chimera of truncated E-cadherin (deletion of the last 70 amino 
acids) fused to a truncated α-catenin that lacks the β-catenin 
binding site (Imamura et al., 1999) abrogated both β-catenin 
(not depicted) and PIPKIγ binding (Fig. 2 A). These results in-
dicate that PIPKIγ binding to E-cadherin is independent of 
α-, β-, or p120-catenin and narrowed the PIPKIγ interaction re-
gion on E-cadherin to residues 837–847. To confi  rm this putative 
PIPKIγ binding site, the last 45 amino acids of E-cadherin were 
truncated (ECD836). This truncation resulted in ablation of 
both β-catenin and PIPKIγ binding (Fig. 2 B). These combined 
data demonstrate that PIPKIγ directly interacts within a region 
including amino acids 837–847 of E-cadherin that is a highly 
conserved domain in the type I classical cadherins (Fig. 2 C).
To examine whether PIPKIγ modulates E-cadherin func-
tion through this direct interaction, we introduced wild-type 
or p120/β-catenin binding site–deleted Myc-HR-ECDT into 
MDCK cells to compete with endogenous E-cadherin for 
PIPKIγ binding (Fig. S2 A, available at http://www.jcb.org/cgi/
content/full/jcb.200606023/DC1). Expression of dimeric ECDT 
that specifi  cally binds PIPKIγ resulted in a loss of AJs identi-
fi  ed by E-cadherin staining and a cytosolic accumulation of 
PIPKIγ in cells, indicating that this phenotype is likely caused 
by sequestration of PIPKIγ (Fig. S2 B). Overexpression of 
PIPKIγ661 was suffi  cient to rescue the loss-of-AJ phenotype 
induced by wild-type Myc-HR-ECDT expression (Fig. S2 C). 
These data establish that a specifi  c interaction between PIPKIγ 
and E-cadherin plays a key role in E-cadherin function and 
  appears to be a limiting factor in AJ formation.
PIPKI𝗄 modulates AJ assembly by 
facilitating E-cadherin trafﬁ  cking
To further determine the functional role of PIPKIγ at AJs, we 
knocked down endogenous PIPKIγ expression using siRNAs. 
Although the cellular E-cadherin content was not changed (Fig. 
3 C), loss of PIPKIγ caused a striking loss of E-cadherin from 
the PM with an apparent accumulation in a cytoplasmic com-
partment (Fig. 3, A and B). Upon loss of PM E-cadherin, the 
cells spread (Fig. 3 A) and underwent a morphological transi-
tion from a polarized epithelial to a more migratory mesenchymal-
like phenotype (Fig. S2 D), supporting the requirement for PIPKIγ 
in E-cadherin–mediated AJs assembly.
In addition, MDCK stable cell lines were generated that 
inducibly express HA-tagged wild-type (PIPKIγ661WT) or 
 kinase-dead  PIPKIγ661 (PIPKIγ661KD), the major endoge-
nous PIPKIγ isoform associated with cadherins (Fig. S1 A). 
Expression of PIPKIγ661WT or PIPKIγ661KD was induced 
by removing doxycyclin from the growth media (Fig. 3 D). As 
shown in Fig. S3 A (available at http://www.jcb.org/cgi/content/
full/jcb.200606023/DC1), upon PIPKIγ661KD expression, both 
E-cadherin PM targeting and AJ assembly appeared defec-
tive compared with parental or PIPKIγ661WT-expressing cells 
(Fig. S3 A). These cells formed E-cadherin–mediated cell–cell 
contacts much more slowly then parental cells when maintained 
at confl  uence (Fig. S3 A, 72 vs. 16 h). These observations are 
consistent with a dominant-negative effect for PIPKIγ661KD 
and also establish a requirement for PI4,5P2 generation in 
AJ assembly.
Our combined results demonstrate a highly specifi  c role for 
PIPKIγ in the assembly of E-cadherin–based AJs, possibly by 
modulating the traffi  cking of E-cadherin. It has been shown that 
depletion of extracellular calcium by EGTA results in a loss of 
E-cadherin homoligation, internalization of E-cadherin,  disassembly 
of AJs, and cell scattering (Chitaev and Troyanovsky, 1998). 
Figure 2.  Determination of the PIPKI𝗄-interacting region on E-cadherin. 
(A) Endogenous PIPKIγ was immunoprecipitated from HEK293 cells over-
expressing wild-type (ECDwt) or the indicated mutant E-cadherin constructs. 
(B) Endogenous PIPKIγ was immunoprecipitated from HEK293 cells over-
expressing wild-type or truncated E-cadherin constructs. The immunoprecipi-
tates were analyzed as indicated. (C) A schematic model representing the 
predicted minimum region on E-cadherin required for PIPKIγ binding. TM, 
transmembrane domain; JMD, juxtamembrane domain; βctnBD, β-catenin 
binding domain. Regions corresponding to βctnBD in E-, N-, P-, and VE-
cadherin were aligned and the conserved residues were highlighted.JCB • VOLUME 176 • NUMBER 3 • 2007  346
To explore possible modulation of E-cadherin traffi  cking by 
PIPKIγ, the exocytic and endocytic traffi  cking of E-cadherin 
was quantifi  ed in parental, PIPKIγ661WT-, and PIPKIγ661KD-
expressing MDCK cells.
To quantify internalization, cell surface E-cadherin 
was biotinylated, followed by extracellular calcium removal 
to induce E-cadherin internalization. Shown in Fig. 3 E, 
PIPKIγ661WT expression considerably enhanced, whereas 
PIPKIγ661KD expression inhibited, E-cadherin internalization 
when compared with parental cells. These data indicate that 
E-cadherin endocytosis is dependent on PIPKIγ661 kinase ac-
tivity and PI4,5P2 generation. E-cadherin internalization can be 
reversed upon replenishment of calcium, providing a method to 
assess the role of PIPKIγ in recycling E-cadherin back to the 
PM. Compared with parental cells, recycling of E-cadherin was 
accelerated when PIPKIγ661WT was expressed, whereas 
PIPKIγ661KD blocked PM deposition of E-cadherin (Fig. 3 F). 
Immunofl  uorescent staining experiments supported these re-
sults, as cells overexpressing PIPKIγ661WT had a dramatically 
faster rate of E-cadherin internalization and also showed an 
  accumulation of both E-cadherin and PIPKIγ in an intracellular 
compartment (Fig. S3 B). In contrast, overexpression of 
PIPKIγ661KD signifi   cantly slowed the internalization of 
E-cadherin (Fig. S3 B).
PI4,5P2 regulates multiple events, including actin reorga-
nization, that could affect E-cadherin assembly and AJ forma-
tion. Because changes in PIPKIγ expression levels may alter 
global PI4,5P2 levels and induce nonspecifi  c responses, cellular 
PI4,5P2 was quantifi  ed by HPLC analysis (Fig. S4, A and B, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200606023/DC1). 
No considerable changes in global cellular PI4,5P2 levels 
were observed when PIPKIγ expression levels or activity was 
altered. The overall structure of the actin cytoskeleton also 
showed no substantial change between PIPKIγ661WT- or KD-
overexpressing cells and control cells (unpublished data). Upon 
depletion of PIPKIγ, cells exhibited an increase in actin stress 
fi  bers and prominent membrane ruffl  es, indicating a morpho-
logical transition from a polarized epithelial to migratory phe-
notype (unpublished data). Further effort was made to observe 
localized changes in PI4,5P2 levels via a bead-based adhesion 
assay using latex beads coated with recombinant E-cadherin 
ectodomain (hE/Fc). As shown in Fig. S4 C, both E-cadherin 
and PIPKIγ661 assembled on the surface of the hE/Fc-coated 
beads but not the poly-lysine–coated control beads, demonstrat-
ing that PIPKIγ661 was recruited to the nascent AJs. Although 
our previous data indicate that PI4,5P2 is necessary for 
E-cadherin assembly, the level of PI4,5P2 detected by the pleck-
strin homology domain along the hE/Fc-coated bead surface 
was similar to the surrounding PM signal (Fig. S4 D), support-
ing the hypothesis that local PI4,5P2 levels are suffi  cient to reg-
ulate E-cadherin assembly.
PIPKI𝗄 links E-cadherin to AP complexes
Multiple components of the traffi  cking machinery, including 
the AP complexes, bind to and are regulated by PI4,5P2 (Martin, 
2001; Roth, 2004; D’Souza-Schorey, 2005). A yeast two-hybrid 
screen using the C terminus of PIPKIγ661 as bait identifi  ed 
interactions with the μ subunits of both AP1B (μ1β; amino 
  acids 135–423) and AP2 (μ2; full length). This was an exciting 
observation as the μ subunits are key regulatory subunits of 
the AP complexes (Bonifacino and Traub, 2003; Folsch, 2005). 
Figure 3. PIPKI𝗄 is required for E-cadherin assembly and trafﬁ  cking. 
(A) MDCK cells were treated with scrambled (Scram.) or PIPKIγ-speciﬁ  c 
siRNA (PIPKIγ1). PIPKIγ (green) and ECD (red) were visualized by indirect 
immunoﬂ  uorescence. Bars, 10 μm. (B) PM or cytosolic ﬂ  uorescence inten-
sity of cells in A was quantiﬁ  ed from six randomly picked ﬁ  elds (5 cells/ﬁ  eld) 
representing three independent experiments were randomly counted. The 
intensity ratio was plotted using SigmaPlot 8.0. Error bars are ± SEM. 
(C) PIPKIγ and E-cadherin protein levels in cells treated with scrambled 
(Scram.) or PIPKIγ-speciﬁ  c siRNAs (PIPKIγ1 and PIPKIγ2) were shown by 
immuno  blots. (D) Protein levels of endogenous and inducibly overexpressed 
PIPKIγ661wild type (Iγ661WT) or knock down (Iγ661KD) in stable MDCK 
lines were determined. Actin was used as a loading control. (E) After sur-
face biotinylation, cells expressing the indicated proteins were lysed be-
fore or after exposure to 0.5 mM EGTA at 18°C to examine the original 
biotinylated E-cadherin (Ori. bio-ECD) and the internalized biotinylated 
E-cadherin (Intern. bio-ECD). Data was quantiﬁ  ed and plotted from four in-
dependent experiments. (F) Calcium restoration subsequent to EGTA treat-
ment induced E-cadherin recycling. The extent of this recycling was 
quantiﬁ  ed in cells expressing the indicated proteins. Data were quantiﬁ  ed 
and plotted from three independent experiments. The values representing 
surface E-cadherin without calcium rescue were used as control. Error bars 
are ± SEM.PIPKIγ REGULATES E-CADHERIN TRAFFICKING • LING ET AL. 347
The direct interaction of PIPKIγ661 with μ1β was confi  rmed 
by direct binding of purifi  ed components (Fig. 4 A, left), and the 
in vivo association was established by coimmunoprecipitation 
(Fig. 4 A, right). PIPKIγ635 did not interact with either μ sub-
unit (Fig. 4 A; Bairstow et al., 2006), indicating that the last 26 
residues of PIPKIγ661 are required. In addition, in vitro bind-
ing of μ1β-adaptin stimulated the kinase activity of PIPKIγ661 
(Fig. 4 D), whereas binding of the soluble ECDT (His-HR-
ECDT) had no effect on PIPKIγ661 activity under these condi-
tions (not depicted).
Epithelial cells typically express two variants of the AP1 
complex, AP1A and AP1B. These AP1 complexes differ only in 
their μ subunits, μ1α and μ1β, which are almost 80% identical 
but target to distinct membrane compartments and have distinct 
functions (Folsch, 2005). To further defi  ne the interaction be-
tween PIPKIγ and the AP1 complexes, we examined the inter-
action between PIPKIγ and both μ1α and μ1β in parallel 
experiments. As shown in Fig. 4 B (left), PIPKIγ661 binds to 
μ1α and μ1β indistinguishably in vitro. The primary binding 
site of the μ subunits is in the last 26 amino acids of PIPKIγ661 
because the C terminus of PIPKIγ661 but not PIPKIγ635 bound 
the μ subunits (Fig. 4 C). A weak interaction between full-
length PIPKIγ635 and the μ subunits was observed under less 
rigorous GST pull-down conditions, where detergent and BSA 
concentrations were decreased. This may be consistent with the 
observations by Krauss et al. (2006), which indicate that there 
may be a secondary μ subunit binding site in the kinase domain 
of the PIPKIs. However, in vivo the interaction is specifi  c for 
PIPKIγ661 and only the interaction between μ1β subunit 
(AP1B) and PIPKIγ661 was detected (Fig. 4 B, right). The 
in vivo specifi  city of PIPKIγ661 for μ1β may be regulated 
by targeting to AP1B-positive membrane compartments via 
an interaction with other traffi   cking components, or the 
PIPKIγ661–AP1B interaction maybe specifi  cally regulated by 
other mechanisms.
Endogenous E-cadherin associates with the PIPKIγ–AP1 
complex (Fig. 5 A). This association was disrupted by internal-
ization of E-cadherin triggered by extracellular calcium deple-
tion (Fig. 5 B). When calcium was restored and E-cadherin 
recycling to the PM was triggered, E-cadherin reassembled into 
the PIPKIγ–AP1 complex (Fig. 5 B). To further examine the 
  interactions between E-cadherin, PIPKIγ661, and AP1, GST 
pull-down assays were performed. Although there is no 
 direct  interaction between the μ1β subunit of AP1 and HR-
ECDT, PIPKIγ661 was suffi  cient to link HR-ECDT to μ1β in a 
GST pulldown experiment (Fig. 5 C). PIPKIγ661 contains a 
Yxxϕ sorting motif (
644YSPL
647; Bonifacino and Traub, 2003; 
Bairstow et al., 2006). The substitution of the tyrosine with phe-
nylalanine in the sorting motif was reported to reduce binding 
to the μ subunits (Ohno et al., 1998; Aikawa and Martin, 2003; 
Bairstow et al., 2006). Concurrent with these results, the Y644F 
mutation diminished PIPKIγ661 binding to μ1β (Fig. 4 C and 
Fig. 5 C), and consequently the amount of E-cadherin C terminus 
pulled down by μ1β was considerably reduced (Fig. 5 C), in-
dicating that the interaction between PIPKIγ661 and μ1β-
adaptin is necessary and suffi  cient to link E-cadherin to the 
AP1B complex.
Because AP complexes play an important role in protein 
transport, our data suggest that PIPKIγ661 regulates E-cadherin 
traffi  cking via a direct interaction with and regulation of AP 
complexes. Such a model would require AP1B for E-cadherin 
transport to the PM. To address this hypothesis, we used LLC-
PK1 cells, which do not express μ1β (i.e., are AP1B defi  cient). In 
LLC-PK1 cells, many basolateral proteins are mistargeted and 
cell polarity is disrupted (Folsch et al., 1999; Folsch, 2005). To 
assess the role of μ1β in E-cadherin transport, GFP–E-cadherin 
was expressed (Fig. 5 D). A small fraction of GFP–E-cadherin 
was able to translocate to the PM; however, the majority was 
observed in a perinuclear compartment, indicating ineffi-
cient transport of E-cadherin to the PM. In cells expressing 
Figure 4. PIPKI𝗄661 associates with AP1B. (A, left) A GST pull-down as-
say was performed using 1 μg of each puriﬁ  ed protein, and one fourth of 
the precipitates were analyzed by immunoblotting as indicated. A stock 
concentration of T7-tagged PIPKIγ661 and PIPKIγ635 was created for the 
GST pull-down assay. (right) A coimmunoprecipitation was performed and 
analyzed as indicated. MDCK cells from conﬂ  uent 100-mm dishes were 
used to make 1-ml lysates for immunoprecipitation. All of each immunopre-
cipitate and 40 μl of each lysate were analyzed. (B, left) GST pull-down 
assays were performed using 1 μg of His-T7–tagged PIPKIγ or GST-fused 
proteins. (right) HEK293 cells were transfected with the indicated con-
structs using calcium phosphate. 48 h after transfection, cells were lysed 
and speciﬁ  c components were immunoprecipitated. The precipitates were 
analyzed by Western blot as indicated. The γ-adaptin subunit was co-
immunoprecipitated with each of the HA-μ subunits, indicating that the 
overexpressed μ subunits were incorporated into AP1 complexes. However, 
when PIPKIγ was overexpressed, γ-adaptin association was weak; whereas 
in the reverse immunoprecipitation, association of PIPKIγ was readily 
  detected. This could result from the competition of other PIPKIγ binding 
partners or from the sensitivity of the anti–γ-adaptin antibody. (C) GST pull-
down assays were performed using 1 μg of His-T7–tagged indicated 
PIPKIγ C terminus or GST-fused proteins. The precipitates were analyzed 
by Western blot as indicated. (D) The indicated amount of puriﬁ  ed GST or 
GST-μ1B was incubated with PIPKIγ at room temperature for 10 min before 
the kinase assay. Kinase activity was quantiﬁ  ed from three independent 
  experiments. Error bars are ± SEM.JCB • VOLUME 176 • NUMBER 3 • 2007  348
GFP–E-cadherin, there was a greatly enhanced recruitment of 
endogenous PIPKIγ to GFP–E-cadherin–containing compart-
ments, which is consistent with the association between PIPKIγ 
and E-cadherin. Upon expression of μ1B in the LLC-PK1 cells, 
GFP–E-cadherin was effi  ciently targeted to sites of cell–cell ad-
hesion, and endogenous PIPKIγ colocalized with E-cadherin at 
AJs (Fig. 5 D). The expression of μ1α, however, did not rescue 
E-cadherin traffi  cking to the PM (unpublished data). These data 
support a model were PIPKIγ associates with E-cadherin and 
this interaction is required for functional recruitment of AP1B 
to PIPKIγ via its interaction with the YSPL motif in the 
PIPKIγ661 C terminus.
PIPKI𝗄 regulates E-cadherin transport by 
recruitment to AP1B compartments
The functional relationship between PIPKIγ and AP1B is re-
inforced by the observation that endogenous PIPKIγ and AP1 co-
localized in vesicle compartments (Fig. 6 A). Both E-cadherin 
and PIPKIγ partially colocalized with γ-adaptin in cytoplasmic 
compartments after removal of calcium (Fig. 6 B, arrows), sug-
gesting a functional link between E-cadherin, PIPKIγ661, and 
AP1 in E-cadherin traffi  cking. Interestingly, when E-cadherin 
recycling was triggered by replenishing calcium, we observed 
that overexpression of PIPKIγ661 enhanced the recruitment 
of AP1B to PM. In parental MDCK cells, AP1 showed typi-
cal perinuclear localization with a small fraction targeting to 
the PM. When PIPKIγ661 was expressed, AP1 targeted to the 
basolateral membrane where it colocalized with E-cadherin 
and PIPKIγ661 (Fig. 6 C). However, when PIPKIγ635 was 
  expressed, AP1 organization was strikingly distinct, as it was 
concentrated in a central perinuclear compartment with no lo-
calization near the PM and little colocalization with E-cadherin 
(Fig. 6 C). In these cells, E-cadherin was largely trapped in 
the cytosol and was not effi   ciently targeted to the PM. In 
PIPKIγ661KD-expressing cells, AP1 weakly localized beneath 
the PM or showed strong colocalization of both E-cadherin and 
PIPKIγ661KD in a large perinuclear compartment, but there 
was little detectable PM E-cadherin (Fig. 6 C). These data again 
support a model where both the PIPKIγ–AP1 interaction and 
PIPKIγ kinase activity are necessary for recruitment of AP1 to 
the PM and the effi  cient traffi  cking of E-cadherin to the PM.
To explore this hypothesis, the internalization and recy-
cling of E-cadherin in cells ectopically expressing PIPKIγ635 
was fi  rst determined. As shown in Fig. 7 A, when internalization 
and recycling of E-cadherin was measured by surface biotinyla-
tion, overexpression of PIPKIγ635 had a dominant-negative ef-
fect and inhibited E-cadherin traffi  cking to and from the PM 
compared with parental cells. Again, these results support a 
functional role for the PIPKIγ661–AP1B interaction in modu-
lation of E-cadherin traffi  cking. Consistent with this conclu-
sion, both ectopically expressed GFP–E-cadherin (Fig. 7 B) and 
endogenous E-cadherin (Fig. 6 C) were sequestered in a cyto-
solic compartment in PIPKIγ635-overexpressing cells, display-
ing a phenotype similar to that observed when endogenous 
PIPKIγ was knocked down.
To further characterize these E-cadherin–containing vesi-
cles in PIPKIγ635-expressing cells, we induced accumulation 
of transferrin receptor (TfnR) in the recycling endosome using 
an established approach (Sheff et al., 1999). As shown in Fig. 7 C 
(top), internalized E-cadherin in parental MDCK cells showed 
partial colocalization with both endogenous PIPKIγ and inter-
nalized TfnR, representing the recycling endosome, and co-
localization among these three proteins was also observed (Fig. 7 C, 
arrows). Interestingly, overexpression of PIPKIγ635, which 
  interacts with E-cadherin but not AP1B, blocked E-cadherin co-
localization with the TfnR compartment, but E-cadherin did co-
localize with PIPKIγ635 (Fig. 7 C, bottom). These data suggest 
that PIPKIγ661 mediates the transport of E-cadherin from the 
trans-Golgi network to the recycling endosome, which has been 
argued to serve as an intermediate between the trans-Golgi net-
work and the basolateral PM (Ang et al., 2004; Folsch, 2005). 
Further, this data establishes that traffi  cking of E-cadherin to 
this compartment requires a functional interaction between 
PIPKIγ661 and AP1B.
If PIPKIγ serves as an adaptor between E-cadherin and 
AP complexes, one would expect that an E-cadherin mutant 
Figure 5. PIPKI𝗄 regulates E-cadherin transport by recruiting E-cadherin 
to AP1. (A) E-cadherin or AP1 were immunoprecipitated from polarized 
MDCK cells. (B) E-cadherin was immunoprecipitated from polarized MDCK 
cells, polarized MDCK cells treated with 2 mM EGTA for 20 min, or polar-
ized MDCK cells treated with EDTA for 20 min followed by regular medium 
for 10 min. The immunoprecipitates were analyzed as indicated. (C) GST 
pull-down assays were performed using 1 μg of GST, GST-μ1B, His-
PIPKIγ661, and His-HR-ECDT and analyzed by immunoblotting as indi-
cated. (D) GFP-fused E-cadherin (ECD-GFP) was transiently introduced into 
parental (μ1B deﬁ  cient)  or  μ1B-expressing LLC-PK1 cells using Lipo-
fectamine 2000 for 8 h and then visualized using ﬂ  uorescence microscopy. 
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lacking or with diminished PIPKIγ binding would not be trans-
ported effi  ciently to the PM. A V832M germline mutation was 
identifi  ed in hereditary diffuse gastric cancer (Yabuta et al., 2002), 
which lacks the ability to mediate cell–cell adhesion or suppress 
invasion (Suriano et al., 2003). In these patients, the wild-type 
E-cadherin gene is repressed, and only the mutant is expressed 
Figure 6. PIPKI𝗄 is functionally related with AP1 and E-cadherin trafﬁ  ck-
ing in vivo. (A) Endogenous PIPKIγ and AP1 colocalize at vesicular com-
partments. PIPKIγ (FITC, green) and AP1 (Texas red, red) were visualized 
in MDCK cells by indirect inmmunoﬂ  uorescence. (B) PIPKIγ and AP1 co-
localize with the internalized E-cadherin. Parental MDCK cells were plated 
on coverslips and allowed to form AJs. They were then treated with 2 mM 
EGTA for 30 min. Cells were ﬁ  xed and indirect immunoﬂ  uorescence stain-
ing was performed using anti-PIPKIγ and anti–γ-adaptin, followed by Cy5-
conjugated anti–rabbit IgG antibody and Texas red–conjugated anti–mouse 
IgG antibodies. Cells were then incubated with 0.5 μg/ml of normal 
mouse IgG at 37°C for 30 min and then with FITC-conjugated anti–
E-cadherin antibodies. Arrows indicate the colocalization of AP1, internal-
ized ECD, and PIPKIγ. (C) PIPKIγ661 recruits AP1 to functional sites of 
E-cadherin recycling. Parental or PIPKIγ isoform–overexpressing MDCK 
cells were treated with 2 mM EGTA for 30 min followed by complete 
medium for 10 min at 37°C to induce the recycling of E-cadherin back to 
the PM. Immunoﬂ  uorescence staining was then performed to visualize AP1 
(γ-adaptin), E-cadherin, and PIPKIγ. Both horizontal and vertical sections 
were collected to show precise subcellular localizations. Bars, 10 μm.
Figure 7.  The interaction between PIPKI𝗄 and AP1B is necessary for 
E-cadherin transport. (A) MDCK cells with or without PIPKIγ635 over-
expression were used to analyze E-cadherin internalization and recycling by 
surface biotinylation as described. Immunoblot data from three independ-
ent experiments were quantiﬁ  ed by ImageJ and plotted with SigmaPlot 8.0. 
Error bars are ± SEM. (B) Parental, PIPKIγ635-, or PIPKIγ661-expressing 
MDCK cells were transiently transfected with ECD-GFP. PIPKIγ was visual-
ized by indirect immunoﬂ   uorescence and ECD-GFP using direct ﬂ  uores-
cence microscopy. (C, top) Parental MDCK cells were incubated at 20°C 
for 2 h, treated with 2 mM EGTA for 30 min, and then ﬁ  xed and triple-
labeled using monoclonal anti-CD71, FITC-conjugated anti–E-cadherin, and 
rabbit anti-PIPKIγ antibodies. (bottom) MDCK cells with the expression of 
HA-PIPKIγ635 induced for 72 h were maintained at 20°C for 2 h. The cells 
were then ﬁ  xed and stained using monoclonal anti-CD71, FITC-conjugated 
anti–E-cadherin, and rabbit anti-HA  antibodies. Arrows indicate the 
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in the carcinomas (Yabuta et al., 2002). Interestingly, the V832M 
mutation lies in the PIPKIγ binding region. To   determine 
whether this mutation impacts PIPKIγ binding, E-cadherin
V832M was introduced into HEK293 cells and its association 
with PIPKIγ was quantifi  ed. This mutant showed a substantially 
reduced ability to bind PIPKIγ (Fig. 8 A). Consistent with 
  published data (Suriano et al., 2003), β-catenin binding was 
normal (not depicted). The basolateral transport of this V832M 
mutation was also explored in both LLC-PK1::μ1β  (unpublished 
data) and MDCK cells using GFP-fused E-cadherinV832M. 
As shown in Fig. 8 B, although the V832M mutant was visual-
ized on the PM as reported by others (Suriano et al., 2003), 
a large accumulation of this E-cadherin mutant was observed 
in a cytosolic compartment. This phenotype was similar to 
that of wild-type E-cadherin observed in the PIPKIγ635-over-
expressing cells (Fig. 7 B) or the LLC-PK1 cells defi  cient 
in μ1β (Fig. 5 D). Wild-type E-cadherin in LLC-PK1::μ1β 
(Fig. 5 D) and MDCK (Fig. 8 B) cells was transported  effi  ciently 
to the basolateral membrane and little was visualized in the 
  cytosol. This result is consistent with a requirement for an inter-
action between E-cadherin and PIPKIγ661 for normal   traffi  cking 
of E-cadherin.
Discussion
Proteins that interact with the ECDT not only mediate the ele-
mental functions of E-cadherin, such as AJ assembly, actin or-
ganization, and cell proliferation, but also regulate E-cadherin 
by modulating its expression and traffi  cking. Here we have 
shown that PIPKIγ directly binds to both E-cadherin and AP 
complexes. This dual interaction supports a mechanism for the 
highly regulated generation of PI4,5P2 to spatially drive the as-
sembly of the traffi  cking machinery and to specifi  cally control 
E-cadherin traffi  cking. These results reveal a novel mechanism 
where PIPKIγ661 functions as both scaffolding and signaling 
molecule during E-cadherin traffi  cking (Fig. 8 C). In this model, 
the AP complex interacts indirectly with the E-cadherin cargo 
via the PIPKIγ661 scaffold, which directly binds to AP com-
plexes via a Yxxϕ sorting motif in its C terminus. This repre-
sents a novel paradigm in which PIPKIγ661 serves as a cargo 
adaptor for AP complexes. Although PIPKIγ661 binds to both 
AP1A and AP1B indistinguishably in vitro, we found that 
PIPKIγ661 preferentially interacts with AP1B in vivo, and reg-
ulation of E-cadherin traffi  cking to the basolateral PM appears 
to be specifi  c for AP1B. AP1A and AP1B both use Yxxϕ sorting 
motifs for cargo recognition. However, despite the substantial 
sequence and structural homology of the μ1 subunits, the AP1 
complexes are targeted to distinct compartments by an unknown 
mechanism (Folsch et al., 2003; Folsch, 2005). PIPKIγ661 
might be specifi   cally recruited to AP1B-containing mem-
brane domains in vivo via an interaction with one or more 
other proteins.
PIPKIγ661 may also have additional lower affi  nity bind-
ing contacts with AP1B, as Krauss et al. (2006) recently re-
ported that multiple PIPKIs bind to the μ2 subunit of AP2 
complex via the kinase domain. In our hands, the YSPL motif of 
PIPKIγ661 was the preferential binding site for the μ subunits 
of AP1 and AP2 (Bairstow et al., 2006), but PIPKIγ635 did bind 
μ1- and μ2-adaptin subunits under less rigorous conditions (un-
published data), suggesting additional lower affi  nity interacting 
sites between the AP complexes and PIPKIγ. For E-cadherin 
traffi  cking, the YSPL motif of PIPKIγ661 is the key interaction 
with AP complexes and subsequent interactions may regulate 
kinase activity. As the kinase domains of the PIPKI isoforms are 
highly homologous, other isoforms of PIPKIs (e.g., PIPKIα) 
may interact with and regulate some AP complex–dependent 
traffi  cking events (Barbieri et al., 2001). These putative interac-
tions could be through the conserved kinase domains or, like 
Figure 8.  The interaction between PIPKI𝗄 and E-cadherin is required for 
E-cadherin transport. (A) Indicated E-cadherin constructs were overexpres-
sed in HEK293 cells, and their association with PIPKIγ was determined, 
quantiﬁ  ed, and plotted from four independent experiments. Error bars are 
± SEM. (B) MDCK cells were transfected with GFP-ECD(V832M). Cells 
were analyzed by ﬂ  uorescence microscopy 8–10 h after transfection. Bar, 
10 μm. (C) A model representing the mechanism for PIPKIγ661-mediated 
E-cadherin trafﬁ  cking. The dual interaction of PIPKIγ661 with the E-cadherin 
dimer and the AP complex provides a mechanism for the speciﬁ  c regulation 
of E-cadherin trafﬁ   cking. This dual interaction mediates the scaffold be-
tween AP complexes and E-cadherin to facilitate the assembly of this cargo 
into the trafﬁ   cking machinery. In addition, the interaction between 
PIPKIγ661 and AP complexes ensures the localized generation of PI4,5P2, 
which regulates the function of AP complexes and other processes in 
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PIPKIγ661, could be mediated by specifi  c binding partners via 
interaction with variable regions of the PIPKI isoforms. Never-
theless, because PI4,5P2 is a key moderator of the recruitment 
and assembly of traffi  cking machinery (Simonsen et al., 2001; 
Roth, 2004), the localized generation of PI4,5P2 at sites where 
E-cadherin and other cargoes are assembled into the traffi  cking 
machinery is an indispensable step in this process. This fi  nding 
suggests that any association between a PIPK and the traffi  ck-
ing machinery must be spatially and temporally regulated. The 
interaction between the PIPKIγ661 and the AP1B complex fi  ts 
this criterion, as this association is detected when E-cadherin is 
recycled back to the PM but not when E-cadherin is being inter-
nalized (Fig. 5 B). This observation supports the concept of cel-
lular signals coordinating the interactions between PIPKIγ661 
and the AP complexes.
A dileucine motif in the juxtamembrane region of the 
ECDT is required for basolateral sorting (Miranda et al., 2001), 
and this motif was proposed to be a cargo signal recognized by 
the β subunit of the AP1 complex (Rapoport et al., 1998). There 
is no solid evidence supporting this interaction at present. How-
ever, if this is true, the E-cadherin–PIPKIγ661–AP1B complex 
could be further stabilized via the interaction of the E-cadherin 
dileucine motif with the β subunit of AP1B. Alternatively, other 
traffi  cking components may recognize this motif and cooperate 
with PIPKIγ and AP1B to provide specifi  city.
The E-cadherin–PIPKIγ661–AP1B interaction serves as a 
foundational signal for exocytic targeting and basolateral sort-
ing of E-cadherin. Indeed, internalized E-cadherin accumulated 
at the recycling endosome, as indicated by internalized TfnR. 
This compartment contained, in addition, endogenous PIPKIγ 
supporting a role for PIPKIγ in traffi  cking though this compart-
ment. Consistent with this observation, the overexpression of 
PIPKIγ635, which binds E-cadherin but not μ1β (AP1B), 
blocked E-cadherin traffi  cking to the TfnR-positive compart-
ment of the recycling endosome. E-cadherin did colocalize with 
PIPKIγ635, indicating that PIPKIγ interacts with E-cadherin in 
this compartment. The combined results demonstrate that the 
association of PIPKIγ661 with AP1B is require for E-cadherin 
traffi  cking through this compartment. The recycling endosome 
is a major site of AP1B, and this further supports our hypothesis 
that PIPKIγ functions as an adaptor in E-cadherin traffi  cking 
and facilitates E-cadherin transport to and from the recycling 
endosome via binding to AP1B and generation of PI4,5P2.
E-cadherin endocytosis can occur in a clathrin-dependent 
(Palacios et al., 2001; Ivanov et al., 2004) or independent 
manner (Paterson et al., 2003). Calcium removal stimulates 
E-cadherin endocytosis by the clathrin-dependent pathway 
(Ivanov et al., 2004). As there is no known Yxxϕ sorting motif 
in the ECDT, the interaction between PIPKIγ661 and E-cadherin 
may recruit AP2 for clathrin-dependent E-cadherin endocytosis. 
Additionally, Arf6 promotes E-cadherin internalization (Palacios 
et al., 2002) and has been shown to associate with and stimulate 
the activity of PIPKIγ (Aikawa and Martin, 2003, 2005). Arf6, 
in cooperation with PI4,5P2, was also shown to directly interact 
with and promote the recruitment of AP2 to the PM (Krauss 
et al., 2003; Paleotti et al., 2005). These combined results sug-
gest that PIPKIγ661, E-cadherin, AP2, and Arf6 may cooperate 
to regulate E-cadherin internalization in epithelial cells. This 
would position PIPKIγ661 as a nexus between AP complexes 
and E-cadherin in endocytic recycling. Nevertheless, there is no 
direct evidence demonstrating that AP2 mediates the internal-
ization of E-cadherin, and further investigation is needed to 
characterize the role of PIPKIγ in E-cadherin endocytosis. 
Our data demonstrates that a loss of PIPKIγ in cultured 
epithelial cells results in the severe mistargeting of E-cadherin, 
suggesting a strong functional connection between PIPKIγ and 
E-cadherin. Interestingly, the PIPKIγ knockout mouse does not 
share the same phenotype as the E-cadherin knockout mouse 
(Larue et al., 1994; Di Paolo et al., 2004). This is not surprising, 
as the knockout phenotypes of other modifi  ers of E-cadherin 
function, such as p120-catenin, differ from that of the E-cadherin 
knockout as well (Pettitt et al., 2003; Davis and Reynolds, 
2006). Considering the existence of multiple pathways for 
E-cadherin traffi  cking, the roles of these E-cadherin modifi  ers 
may only become apparent during the development of specifi  c 
tissues in later stages of animal development.
Dimerization is an essential property of E-cadherin as-
sembly driving AJ formation (Yap et al., 1997). The association 
of both PIPKIγ and p120 catenin with the E-cadherin dimer 
may be a mechanism to functionally regulate E-cadherin assem-
bly and could promote AJ formation by stimulating E-cadherin 
clustering. Because PIPKIγ specifi  cally binds to E-cadherin di-
mers, the in situ PI4,5P2 generation resulting from this interac-
tion may drive other local complementary cellular events, such 
as actin reorganization (Janmey and Lindberg, 2004). Actin 
  assembly is important not only in AJ assembly but also for 
E-cadherin internalization/exocytosis (D’Souza-Schorey, 2005). 
The association of PIPKIγ with E-cadherin may be crucial for 
downstream signaling, as Rac and phosphoinositide-3 kinase 
are activated by E-cadherin and both regulate the stability of 
AJs by modulating actin assembly (Noren et al., 2001; Yap and 
Kovacs, 2003; D’Souza-Schorey, 2005). Phosphoinositide-3 
  kinase requires PI4,5P2 for signaling, and Rho family small 
G proteins regulate some PIPKI isoforms (Fruman et al., 1998). 
As a result, PIPKIγ may also regulate AJ assembly through 
  local cooperation with phosphoinositide-3 kinase and small 
G protein signaling.
The generation of phosphoinositide messengers upon 
  assembly of AJs has implications beyond simple control of 
E-cadherin traffi  cking. Because E-cadherin is a major suppressor 
of invasion of epithelial tumors, the cell biological data suggest 
that PIPKIγ may play a similar role. In exploring this possibil-
ity, we have discovered that a loss of E-cadherin correlates with 
a loss of PIPKIγ in human breast cancers (unpublished data). 
This fi  nding supports a physiological role for PIPKIγ in assem-
bly of E-cadherin junctions and potentially a role in progression 
of epithelial tumors.
Materials and methods
Constructs and antibodies
The C terminus of E-cadherin was ampliﬁ  ed by PCR and constructed into 
normal or modiﬁ  ed (Ling et al., 2003) pET28 to generate the His-tagged 
E-cadherin tail or HR–E-cadherin tail, which were then subcloned into 
pCMV-Myc vector (CLONTECH Laboratories, Inc.). Wild-type E-cadherin, JCB • VOLUME 176 • NUMBER 3 • 2007  352
E-cadherin∆p120ctn, E-cadherin∆βctn, and E-cadherin/αctn were 
  provided by B. Gumbiner (University of Virginia, Charlottesville, VA). 
E-cadherin836 was ampliﬁ  ed by PCR, and E-cadherinV832M was gener-
ated using the QuikChange II Site-Directed Mutagenesis kit (Stratagene) 
according to the manufacturer’s instructions. Both μ1α and μ1β constructs 
were provided by I. Mellman (Yale University, New Haven, CT). cDNAs en-
coding N-terminal truncated μ1α and μ1β (1–135 aa truncated) were ampli-
ﬁ  ed by PCR and subcloned into pET42. All of the PIPKI constructs were 
created as described previously (Ling et al., 2002, 2003; Bairstow et al., 
2006). Duplexes of siRNA oligos (for both human and mouse: aagttctat-
gggctgtactgc, aaggacctggacttcatgcag; for canine: gaaggctcttgttcacgat) 
were synthesized by Dharmacon.
Monoclonal antibodies for E-cadherin (recognizing the C terminus), 
N-cadherin, human VE-cadherin, p120catenin, β-catenin, γ-adaptin, and 
FITC-conjugated anti–E-cadherin were purchased from Transduction Labo-
ratories. The H68.4 monoclonal anti-CD71 (TfnR) antibody was purchased 
from BioGenex Inc. Polyclonal PIPKIγ antibody was generated as de-
scribed previously (Ling et al., 2002). Regular mouse and rabbit IgG and 
secondary antibodies were obtained from Jackson ImmunoResearch Labo-
ratories. Anti-HA antibody was purchased from Covance. Anti-Myc and 
FITC-conjugated anti-Myc were obtained from Upstate Biotechnology. HRP-
conjugated anti-GST antibodies were purchased from GE Healthcare. 
Anti–E-cadherin antibodies recognizing the ectodomain were purchased 
from Zymed Laboratories (monoclonal, for immunoblotting) and Sigma-
  Aldrich (rat monoclonal, for immunoﬂ  uorescence).
Cell culture, transfection, immunoﬂ  uorescence, and confocal microscopy
MDCK-TetOff cells (CLONTECH Laboratories, Inc.) and HEK293 cells were 
cultured in Dulbecco’s modiﬁ  ed eagle medium (Mediatech, Inc.) supple-
mented with 10% FBS (Invitrogen). Lysates of human umbilical vein endo-
thelial cells were obtained from E. Bresnick (University of Wisconsin-Madison, 
Madison, WI). MDCK cells were transfected using FuGENE 6 (Roche) for 
48 h, and then 100 μg/ml hygromycin B was added to the medium to se-
lect stable clones and 10 mg/ml doxycycline was used to suppress PIPKIγ 
expression. To induce expression, doxycycline was removed for 72 h. 
HEK293 cells were transfected using the calcium phosphate–DNA copre-
cipitation method for 48 h. For siRNA knockdown, MDCK cells in a 6-well 
plate were transfected twice at 48-h intervals with 5 pmol/well siRNA us-
ing the calcium phosphate–DNA coprecipitation method. Cells were ana-
lyzed 48 h after the second transfection. LLC-PK1 cell lines were provided 
by I. Mellman and cultured as described previously (Folsch et al., 1999).
Indirect immunoﬂ   uorescence and confocal microscopy were per-
formed as described previously (Ling et al., 2002). For triple labeling, dou-
ble labeled samples were blocked by 0.5 mg/ml of normal mouse IgG in 
3% BSA/PBS at 37°C for 30 min, rinsed in PBS twice, and incubated with 
FITC-conjugated anti–E-cadherin or anti-Myc antibodies in 3% BSA/PBS at 
37°C for 1 h. Confocal images were acquired using photomultiplier tubes 
through LaserSharp2000 (Carl Zeiss MicroImaging, Inc.) with a PlanApo 
100× oil objective (NA 1.4) on an inverted microscope (Eclipse TE2000; 
Nikon) with Radiance 2100 MP Rainbow (Bio-Rad Laboratories). Z series 
were created by sequentially scanning FITC, Texas red, or Cy5 channel at 
0.3-μm steps. Single sections were exported to Photoshop CS2 (Adobe) for 
ﬁ  nal image processing. Fluorescence intensity was quantiﬁ  ed using ImageJ 
1.62 (National Institutes of Health) and plotted using SigmaPlot 8.0.
Immunoprecipitation, GST pull-down assay, and immunoblotting
Cells were lysed in lysis buffer (50 mM Tris⋅HCl, pH 7.5, 150 mM NaCl, 
0.5% NP-40, 1 mM EDTA, 1 mM PMSF, and 10% glycerol), and then used 
for immunoprecipitation (Ling et al., 2002). The immunocomplexes were 
separated by SDS-PAGE and analyzed. Unless stated, immunoprecipi-
tations were performed using 800 μl of cell lysate from one conﬂ  uent 60-mm 
dish. One fourth of each precipitate and 20 μl of each lysate were 
  analyzed. GST-tagged PIPKIα, PIPKIγ635, and PIPKIγ661, His-tagged 
E-cadherin, or HR-E-cadherin tail were puriﬁ  ed from Escherichia coli, and 
GST pull-down assays were performed (Ling et al., 2003). One fourth of 
the GST beads for each pull down were loaded on the gel and 20 μl of 
each puriﬁ  ed protein was loaded as an input control. Images were scanned 
and exported to Photoshop CS2 for ﬁ  nal processing. Intensity of bands 
was quantiﬁ  ed using ImageJ 1.62 and plotted using SigmaPlot 8.0.
Calcium depletion, surface biotinylation, and trafﬁ  cking of E-cadherin
Cells were allowed to grow on coverslips for 72 h to reach conﬂ  uence and 
were then incubated with 2 mM EGTA for 20 min before performing indi-
rect immunoﬂ  urescence. Conﬂ  uent MDCK cells grown in 24-mm-diam Tran-
swells (Costar) were biotinylated by 1 mg/ml sulfo-NHS-SS-biotin (Pierce 
Chemical Co.) and analyzed as described previously (Le et al., 1999). 
Cells were lysed in 500 μl of lysis buffer and one third of the precipitates 
were analyzed. Internalization of E-cadherin was induced by 0.5 mM 
EGTA at 18°C. To measure the recycling of E-cadherin, MDCK cells were 
treated with 2 mM EGTA for 40 min at 37°C and chased in normal me-
dium, and then surface biotinylation was performed.
PIPK activity assay
Activity of 10 μg of puriﬁ   ed recombinant PIPKIγ proteins was assayed 
against 20 μg of Folsch Brain Extract III as previously described (Di Paolo 
et al., 2002). Kinase activity was quantiﬁ  ed using Storm 840 (Molecular 
Dynamics) and plotted using SigmaPlot 8.0.
Online supplemental material
Fig. S1 shows that PIPKIγ directly binds E-cadherin. Fig. S2 shows that the 
direct interaction with PIPKIγ is important for E-cadherin assembly. Fig. S3 
shows that functional PIPKIγ is required for E-cadherin assembly. Fig. S4 
shows that a modiﬁ  cation of PIPKIγ activity has no effect on global PI4,5P2 
level. Online supplemental material, including Figs. S1−S4 and supple-
mental Materials and methods, is available at http://www.jcb.org/cgi/
content/full/jcb.200606023/DC1.
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